Skip to main content
. Author manuscript; available in PMC: 2018 Mar 5.
Published in final edited form as: Vaccine. 2016 Nov 18;35(1):109–117. doi: 10.1016/j.vaccine.2016.11.018

Table 1.

Baseline demographic and practice characteristics, by site, by intervention group and overall

Site N 11–13 years old, % Female, % Non-white, % Commercial Health Insurance, %
Intervention sites
  A 1263 42.9 49.4 4.8 82.6
  C 390 36.9 51.5 67.7 21.5
  D 1815 36.0 51.0 2.4 74.3
  E 133 30.1 60.2 51.9 11.3
  F 987 47.7 52.1 3.5 71.1
  G 136 31.6 47.8 11.0 55.9
  H 99 36.4 51.5 37.4 49.5
  I 66 34.9 56.1 18.2 31.8
  J 53 34.0 49.1 98.1 18.8

Intervention total 4942 39.9 49.6 12.0 62.2

Control sites
  L 1597 35.2 49.2 1.6 69.6
  M 704 39.5 48.4 1.3 77.7
  N 933 44.0 50.3 82.4 23.4
  O 143 35.7 52.5 46.1 16.1
  P 86 24.4 61.6 2.3 38.4
  Q 160 18.1 50.6 5.0 60.6
  R 117 28.2 51.3 5.1 67.5
  S 103 32.0 44.7 3.9 64.1
  T 913 36.6 48.2 23.4 71.9
  U 921 39.5 49.5 9.0 84.0
  V 242 36.0 53.3 83.5 32.6

Control total 5919 37.2* 51.1 23.4* 67.8*
Overall 10861 38.4 50.3 18.2 64.7
*

P <0.001 for differences between intervention and control groups